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Background: The World Health Organization recognizes the antibiotic resistance
problem as a major health threat in the twenty first century. The paper describes an effort
to fight it undertaken at the verge of two industries—healthcare and Data Science. One of
the major difficulties in monitoring antibiotic resistance is low availability of comprehensive
research data. Our aim is to develop a nation-wide antibiotic resistance database using
Internet search and data processing algorithms using Russian language publications.
Materials andMethods: An interdisciplinary team built an intelligent Internet search filter
to locate all publicly available research data on antibiotic resistance in Russia and Eurasia
countries, extracted it, and collated it for analysis. A databasewas constructed using data
from 850 original studies conducted at 153 locations in 12 countries between 1992 and
2014. The studies contained susceptibility and resistance rates of 156 microorganisms
to 157 antibiotic drugs.
Results: The applied search methodology was highly robust in that it yielded search
precision of 58 vs. 20% in a typical Internet search. It allowed finding and collating
within the database the following data items (among many others): publication details
including title, source, date, authors, etc.; study details: time period, locations, research
organization, therapy area, etc.; microorganisms and antibiotic drugs included in the
study along with prevalence values of resistant and susceptible strains, and numbers of
isolates. The next stage in project development will try to validate the data by matching it
to major benchmark studies; in addition, a panel of experts will be convened to evaluate
the outcomes.
Conclusions: The work provides a supplementary tool to national surveillance systems
in antibiotic resistance, and consolidates fragmented research data available for 12
countries for a period of more than 20 years.
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BACKGROUND
Antibiotic resistance is resistance of a microorganism to an
antibiotic drug that was originally effective for treatment of
infections caused by it (World Health Organization, 2015).
This resistance becomes an increasingly serious threat to global
public health that requires urgent action across all government
sectors and society (Boucher et al., 2009; Carlet et al., 2014;
Llor and Bjerrum, 2014). Without urgent action, we are heading
for the second pre-antibiotic era, in which common infections
and minor injuries can once again kill (Livermore and British
Society for Antimicrobial Chemotherapy Working Party on The
Urgent Need: Regenerating Antibacterial Drug Discovery and
Development, 2011; Appelbaum, 2012; Roca et al., 2015). The
World Health Organization (WHO)’s 2014 report on global
surveillance of antimicrobial resistance revealed high rates of
resistance in all regions of the world (WorldHealthOrganization,
2014). Yet, only a few countries (34 out of 133 participating
in the WHO’s survey) have a comprehensive national plan
to fight resistance to antibiotics and other antimicrobial
medicines. Significant gaps exist in many countries in tracking
of antibiotic resistance (World Health Organization, 2014).
This paper presents an approach that yields consolidated data
for monitoring, and therefore controlling, resistance profiles.
The resultant database built on publicly available research data
on antibiotic resistance using a combination of a customized
Internet search engine and data processing techniques provides
a novel instrument for resistance analysis. It can become a
supplementary tool for national surveillance systems in some
countries, in particular in Russia and Eurasia, consolidating
numerous studies of antibiotic resistance undertaken by a
number of research centers into a single, nation-wide, picture.
Used together, existing and evolving resistance data management
approaches can ensure effective surveillance, which can reveal
patterns and identify trends and outbreaks.
The problem of microorganisms’ resistance to drugs has
spread worldwide and is acute in many countries. Knowing
susceptibility of particular microorganisms to antibiotics is
crucial for their rational prescription that, in turn, leads to
successful treatment of diseases. This is what patients, doctors,
pharmaceutical companies, and society alike, wish to achieve.
National antibiotic resistance surveillance systems in Russia and
Eurasia are still taking their first steps toward maturity. One
of the major difficulties in monitoring resistance profiles is
low availability of comprehensive data on antibiotic resistance
coming from various research studies. Such data are highly
fragmented and not being applied systemically. Only a handful
of top microbiology research centers provide a clear view on
the results of their studies by regularly publishing reports in
Russian and Eurasian national journals. Studies of other research
groups remain virtually unnoticed, although they provide a
valuable source of antibiotic resistance data derived from day-
to-day practice. Ideally, all available records should be merged
together within a single database that will most certainly
prove to be invaluable for the national healthcare system as
the source of real evidence on antibiotics resistance. This is
where the interdisciplinary project undertaken at the verge of
two industries: healthcare, presented by AstraZeneca, and data
science, presented by Yandex Data Factory, can help national
surveillance systems of Russia and Eurasia to evolve.
Inspired by the fact that the Internet has become the
megastore of various data, and rapid evolution of data processing
technologies, a hypothesis was developed that some new useful
knowledge for the national surveillance system can emerge from
readily available data through the combination of Internet search
and data processing algorithms. It implied that fragmented
research studies on antimicrobial resistance published in the
Russian language on the Internet could be successfully discovered
and collated into a nation-wide antibiotic resistance database.
Only publicly available research data not protected by copyright
or other rights would be considered for inclusion. Such a database
would not only allow to view the current perspective, but also to
see the dynamics of pathogenic microorganisms and—if coupled
with antibiotics consumption data—could establish a basis for
identifying trends and making forecasts. The approach presented
here complements previous attempts (Harbarth and Emonet,
2006; Brandt et al., 2014) to use the Internet for gathering data
on antibiotic resistance, yet its novelty is in (a) retrieving data
from the Internet not limited by particular websites, (b) storing it
in the database for subsequent use, and (c) targeting materials in
the Russian language.
RESULTS AND DISCUSSION
The Internet search filter designed for the project reduced
the working set of documents from more than 1012 to
nearly 60,000. Still, this provided a very suboptimal filtering
algorithm demanding further refinements in identifying relevant
documents from the entire pool. In order to significantly improve
quality, the search model was optimized by three consecutive
iterations of machine learning. At the start of each iteration, a
group of assessorsmanually classified top documents from the list
ranked by the current model, defining their relevance and type.
These classifications were then fed into the search model, and the
relevance score for each document was recalculated. After each
iteration, the percentage of relevant documents in the first 1000
positions improved significantly, growing from the original 2% to
more than 58% eventually. Altogether, assessors classified 4385
documents to reach this level. As an outcome of applying the
refined search algorithm, a list of URLs was produced, ordered
by the underlying document relevance score in the descending
order.
While at the start of the project the target search precision
of 20% was set (Robertson and Hull, 2001), it was actually
possible to exceed this target significantly. Thanks to machine
learning with the help of manual document classification, the
search algorithm provided precision of 58% for the top 1000
documents.
At first, consideration was given to automatic document
parsing and data extraction. An experiment was carried out using
a sample set of 50 documents, with the aim of determining the
technical capability of automatically identifying and extracting
target datasets from the documents. It was observed that datasets
were represented in a diverse variety of styles: tables, charts,
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FIGURE 1 | Sample antibiotic resistance data from the city of Yakutsk
(Russia). The chart shows resistance of Pseudomonas aeruginosa to
Gentamicin.
histograms and—unsurprisingly—free text. In particular, 60%
of sample documents contained table data, 20%—free text, and
the remaining 20%—charts or histograms. Within table format,
nearly one third of tables had microorganism names listed in
headers, another third—in rows, and the rest—in table captions
or adjacent text. The most difficult format for data parsing,
though, was charts and histograms as it required an OCR system
able to extract numeric data from graphics. Adding to the
complexity were abbreviations and various formats of names and
numbers. The conclusion derived from the experiment was that
wide variety of data representation formats required a highly
complicated automatic parsing algorithm that would adapt its
fact extraction model to virtually every document.
In parallel with this, manual document screening was under
way to identify relevant documents in the set of 58,821
documents found automatically. As at some point the number of
relevant documents in the set was evaluated slightly below 1000,
the option of manual data extraction was chosen. Automatic data
extraction and transformation to a single format was not justified
in our case and would be deemed reasonable only for volumes of
documents a few orders of magnitude higher.
The antimicrobial resistance database was designed and
developed specifically for the project using one of popular
relational database management systems. The data management
team extracted resistance data from documents and stored it
in the database for further analysis. Eight hundred and fifty
original studies were collated to have been published in the
period between 1992 and 2014, containing susceptibility and
resistance rates of 156 microorganisms to 157 antibiotic drugs.
The studies were conducted in 153 locations of 12 countries.
While the project targeted only Russian language studies on
antibiotic resistance, multiple publications in Russian from
several Eurasia countries—Georgia, Kazakhstan, Uzbekistan,
etc.—were also discovered during its course. Figures 1, 2 contain
sample data.
The project confirmed the fact that studies conducted in
Russia use different interpretive criteria and breakpoints, e.g.,
EUCAST, CLSI, and local Russian guidelines. For instance, the
share of NCCLS/CLSI-compliant studies reaches 27% in the
resultant database. For correct stratification of data in each
FIGURE 2 | Sample antibiotic resistance data from the cities of
Karaganda (Kazakhstan) and Tbilisi (Georgia). The chart shows
resistance of Pseudomonas aeruginosa to Ciprofloxacin.
FIGURE 3 | Statistics on publications on antimicrobial resistance in
Russia. The dynamics of number of publications is clearly linear. The downfall
in 2014–2015 is likely due to the typical lifecycle of a study in which 1–2 years
elapse between the study and publication.
susceptibility category, a reference to interpretive criteria was
stored for each study. At the same time however, the database
currently has no feature to account for different susceptibility
rules used in different years.
Another limitation of the current database is that is lacks a
simple way of distinguishing between community-acquired and
hospital-associated infections. Currently, this can be achieved
using a rather complex set of attributes. Further modifications of
the database will make it possible to differentiate these two types
of infection easily.
An interesting by-product of the project was the statistics on
yearly number of publications in the subject matter area. In the
last 5 years, the number of new articles fluctuated in the range of
50–70 per year; see Figure 3 for details.
The next stage in project development will attempt to validate
the collected data by matching it against some major benchmark
studies, and establish Advisory Boards of experts to evaluate the
outcomes.
In its current format, the output of the project can only be
used by the Russian-speaking audience. However, with moderate
efforts, it can be converted to English thus making it accessible by
much wider audience.
The project has shown that it can be instrumental in creating
a holistic antibiotic resistance surveillance framework. Its main
value is in discovering and consolidating multiple fractions of
data that in many instances are left outside the mainstream
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TABLE 1 | List of search keywords.
Antibiotic names Microorganism names General keywords
Avibact Acinetobacter Antimicrobial
Amikacin Aeruginosa Antibiotic
Amoxicillin Aureus Resistance
Ampicillin Baumannii Susceptibility
Aztreon Burkholderia
Azithromycin Campylobacter
Bedaquiline Catarrhalis
Benzylpenicillin Cepacia
Cefaclor Clostridium
Cefadrox Coli
Cephalexin Corynebacterium
Cefazolin Difficile
Cefep Enterobacter
Cefix Enterobacteriaceae
Cefotax Enterococcus
Cefoxitin Escherichia
Cefpodox Faecalis
Ceftaroline Faecium
Ceftazid Flavobacter
Ceftobiprol Flexneri
Ceftriaxone Gonorrhea
Cefurox Haemophilus
Chloramphenicol Helicobacter
Ciprofloxacin Influenza
Clarithromycin Jejuni
Clavulanic acid Klebsiella
Clindamycin Listeria
Cloxacillin Maltophilia
Colistin Meningitis
Dalbavancin Mirabilis
Daptomycin Monocytogenes
Delamanid Moraxella
Dicloxacillin Multocida
Doripen Mycobacterium
Doxycycline Neisseria
Erythromycin Oxytoca
Ertapen Pasteurella
Fidaxomicin Pneumoniae
Flucloxacillin Proteus
Furazidin Pseudomonas
Gentamicin Pylori
Imipen Pyogenes
Levofloxacin Salmonella
Linezolid Serratia
Mecillinam Shigella
Meropen Staphylococcus
Metronidazol Stenotrophomonas
Minocycline Streptococcus
Moxifloxacin Tuberculosis
Mupirocin
Nalidix
(Continued)
TABLE 1 | Continued
Antibiotic names Microorganism names General keywords
Netilmicin
Nitrofurantoin
Norfloxacin
Ofloxacin
Oritavancin
Oxacillin
Pefloxacin
Phenoxymethylpenicillin
Phosphomycin
Piperacillin
Rifampicin
Roxythromycin
Spectinomycin
Telavancin
Telithromycin
Tetracycline
Teicoplanin
Ticarcillin
Tedizolid
Tigecycline
Tobramycin
Trimetopr
Vancomycin
Some antibiotic and microorganism names are intentionally truncated.
analysis. The presented approach by no means purports to be the
universal solution; it merely serves to provide a supplementary
tool. Its shortcomings are obvious: uncertain set of source data,
sizeable number of documents to screen for relevance, and
laborious data extraction. Further interpretation of collected data
needs to be mindful of the fact that quality of studies and
underlying data was accepted “as is” and not questioned.
CONCLUSIONS
It appears prudent to combine outcomes of this project with
other approaches and research tools in order to create an
integrated picture of antibiotic resistance at national level
including also the epidemiology outlook. In particular, its
extensive database can be one of the cornerstones on which
data management system for the surveillance framework is
built. It will be of great worth if such a system is established
in Russia and Eurasia countries and populated with the
most up-to-date research data provided by laboratories and
research centers in order to successfully combat antibiotic
resistance.
MATERIALS AND METHODS
Search Inputs
Initially, a group of medical experts formed a list of keywords
and names, carefully selecting those pertaining to the topic
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(Table 1). The second list, containing non-inclusive words—
e.g., virus, fungus—was composed to exclude documents
seemingly relevant yet belonging to a different subject. This,
in part, helped set an important constraint in the algorithm,
namely, to consider as irrelevant all non-original publications,
e.g., reviews, clinical recommendations, articles on treating
infectious diseases, etc. Another input to the search model
was the target document structure for which to search, as
it was observed that relevant materials are often embedded
within a complex document, e.g., a volume of articles or a
conference book.
The source data came from the Yandex content system,
a distributed data store keeping all freely accessible Internet
pages scanned by the Yandex web crawler. Once a document
is loaded in the content system, it undergoes several stages
of processing during which a multitude of numerical features
and statistics of the document are calculated and included
in the search index—the primary data structure enabling
keyword search. The search engine and index were provided by
Yandex Data Factory, the machine learning and data analytics
experts who use data science to meet particular business needs
involving working with large amounts of data, by building
upon the advanced technologies of their parent company,
Yandex.
Search Model
Having received the search requirements, a group of software
engineers and data scientists translated them into a set of
search rules, included in the search model, and applied to
the search index. The search model suggested that relevant
documents are a subset of N documents with highest relevance
scores. The value of N is arbitrarily chosen depending on
desired levels of search precision and recall that are the
main characteristics of search quality. They are defined as
follows:
• Search precision is the proportion of documents in the
selected subset that are relevant.
• Search recall is the proportion of all the relevant documents
that are selected.
A few groups of document features were calculated in order to
determine document relevance:
(1) Vector SpaceModel (Salton et al., 1975) representation of the
text (i.e., counts of all possible words);
(2) features based on word embedding (Mikolov et al., 2013; Le
and Mikolov, 2014);
(3) website from where the document was downloaded;
(4) document features used in Yandex ranking algorithm;
(5) counts of keywords from relevant and non-inclusive lists;
(6) positional properties of relevant keywords such as a
difference between first and last occurrence of such
keywords.
Using these features as the basis, machine learning was applied to
train the classification model to automatically screen documents
as relevant or irrelevant. The machine learning toolset was based
on MatrixNet—Yandex’s implementation of gradient boosting
over oblivious decision trees. The resulting model calculates
the relevance score for each document—the measure of its
confidence in the document’s belonging to the positive (or
relevant) class.
Quality Metrics
Search quality metrics at N = 1000 are quite illustrative; of the
first 1000 documents, 636 were classified by assessors. Precision
at N = 1000 equals 57.9%, and the recall is 94.8%. Precision
of 50% is reached at N = 1186, with recall of 97.1%. Precision
FIGURE 4 | Search precision and recall. Density of relevant documents in the set sorted by the relevance score decreases as the size of the set grows bigger. The
more relevant documents are placed in the first thousand documents, the less are found in the second, etc. Therefore, search precision decreases monotonically
toward the end of the selected set. For our task, this implies that only the first few thousand documents need to be analyzed where the density of relevant documents
is nearing maximum. Nearly 99% of relevant documents are discovered within the first 2000 documents.
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of 80% is reached at N = 592, with recall of 77.6%. Maximum
level of recall (100%) is reached at N = 2307, at which point
the precision is only 26.5%. With N = 611, precision and recall
are leveled and equal to 78.4%. Figure 4 shows the precision
and recall curves depending on the number (N) of selected
documents.
Data Extraction
Once relevant documents were identified, the data extraction
stage began. The search model was created on the premise that
relevant documents contain—whether in table or free text form—
basic datasets of antibiotic resistance data. Datasets were bound
to include the following mandatory items: antibiotic drug name;
microorganism; measures of resistance and susceptibility; year of
study; city or territory of study; and number of samples studied.
As the option of manual data extraction was chosen, a data
management team was formed and trained in order to populate
the antimicrobial resistance database. Throughout the process of
collating the data in the database, various automatic and manual
data checks and validations were applied to ensure data quality.
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